Kelajakdagi narxning foydaga nisbati: ardenthealth.com (ARDT)

Ardent Health Corp - ARDT emitenti grafik logotipi

Ko'p ixtisoslashgan klinikalar tomonidan ta'minlanadigan barqaror foyda oqimi Ardent Health Partners, Inc. (ARDT) moliyaviy barqarorligini ta'minlaydi. GURU.Markets platformasida kompaniyaning kelajakdagi P/E trayektoriyasi bozor ishonchi dinamikasini aks ettiradi, bunda 14.20 bazaviy qiymat sifatida qayd etilgan. Ambulator markazlar va IT optimallashtiruvi hisobiga tarmoqning o'sishi kengayishni kuchaytiradi. Biroq, tibbiy uskunalar yetishmovchiligiga sabab bo'ladigan global logistika uzilishlari biznesga bilvosita ta'sir ko'rsatmoqda.

ardenthealth.com - ARDT Kapitalizatsiyaning kelajakdagi foydaga nisbati (davr: 19.07.2024 - 14.11.2026)

Ardent Health Corp (ARDT) moliyaviy va bozor koʻrsatkichlari kesimi

- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning jamlanma tahliliyoti:Ardent Health Partners
Ardent Health Corp brend mahsuloti

Ardent Health Partners, Inc. (ARDT) ning mahalliy bozorlardagi oligopolistik maqomi raqobatchilar uchun kirishning yuqori to'siqlarini yaratadi. Kompaniyaning prognoz qilinayotgan P/E koeffitsiyenti joriy kapitalizatsiyaning kutilayotgan sof foyda o'sishi bilan qanchalik asoslanganini aks ettiradi. Ushbu metrika bozor qiymatini kelajakdagi daromadlar bilan solishtirib, investorlarning ishonchini o'lchaydi. Grafikning barqarorligi tibbiy tarmoqlarning samarali integratsiyasini tasdiqlaydi, multiplikator dinamikasi esa kapitalning adolatli qiymatini belgilaydi.

Ardent Health Partners, Inc. (ARDT) raqobatchilari

Forvard P/E multiplikatori HCA|THC - Prognoz qilingan narx-foyda nisbati|Kelajakdagi narxning foydaga nisbati Fresenius Medical Care Corp FMS|SOLV: Narxning kelajakdagi foydaga nisbati|EHC: Prognoz qilingan narxning foydaga nisbati|Universal Health Services - Kapitalizatsiyaning kelajakdagi foydaga nisbati|DVA: Forvard P/E multiplikatori|RadNet Inc (RDNT) - Forvard P/E multiplikatori|Kelajakdagi narxning foydaga nisbati Option Care Health Inc|SGRY: Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori PINC|nationalvision.com - Narxning kelajakdagi foydaga nisbati|Forvard P/E multiplikatori PGNY (Progyny)|Select Medical Corporation (SEM) - Prognoz qilingan narx-foyda nisbati|ASTH - Kelajakdagi narxning foydaga nisbati|MD (Pediatrix Medical) - Narxning kelajakdagi foydaga nisbati|USPH (usph.com) - Prognoz qilingan narxning foydaga nisbati|PNTG: Kapitalizatsiyaning kelajakdagi foydaga nisbati|Prognoz qilingan narxning foydaga nisbati ORGO|NUTX: Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori AUNA|SBC (SBC Medical Group Inc) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori EOLS (Evolus, Inc.)|chs.net (CYH) - Prognoz qilingan narx-foyda nisbati|Beauty Health - Forvard P/E multiplikatori|MDWD - Forvard P/E multiplikatori|Biote Corp (BTMD) - Kelajakdagi narxning foydaga nisbati|JYNT (The Joint) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati DCGO|PIII (P3 Health) - Kapitalizatsiyaning kelajakdagi foydaga nisbati|Forvard P/E multiplikatori GANX|EUDA (EUDA Health Holdings) - Kelajakdagi narx-foyda multiplikatori|Basel Medical Group Ltd - Prognoz qilingan narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori CLGN|CUPR - Kelajakdagi narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati CCM|AMS: Forvard P/E multiplikatori|MEDIROM Healthcare Group Inc. (MRM) - Forvard P/E multiplikatori|Kelajakdagi narxning foydaga nisbati Avalon GloboCare Corp|DHAI: Kelajakdagi narx-foyda multiplikatori|Prognoz qilingan narxning foydaga nisbati XAGE (Longevity Health Holdings)|Kapitalizatsiyaning kelajakdagi foydaga nisbati NIVF|Kelajakdagi narxning foydaga nisbati ATI Physical Therapy, Inc. ATIP|CMAX: Narxning kelajakdagi foydaga nisbati|Kindly MD Corp - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati ModivCare Corp|Novo Integrated Sciences (NVOS) - Kelajakdagi narxning foydaga nisbati|SunLink Health Systems, Inc. - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati IMAC Holdings